A US panel voted in favour of wider use of Abbott Laboratories’ rheumatoid arthritis drug, Humira. The drug is already approved for six other conditions and now it has been backed to treat ...
I often say that investing rarely has a dull moment, which is why I find it so fascinating. The beginning of 2025 certainly ...
The fully human anti-TNF-α antibody adalimumab (Humira; Abbott) was approved by the FDA in 2007. This year, it has been joined by natalizumab (Tysabri; Elan/Biogen-Idec), a humanized antibody ...
Winter founded Cambridge Antibody Technology in 1989, which first discovered adalimumab using phage display technology as part of a development partnership with BASF Pharma. After Abbott bought ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback